Recent Additions to the WNV Literature

From: Lois Levitan <lcl3_at_cornell.edu>
Date: June 17 2005

The scientific and outreach literature has been enriched by the
following recent additions. Articles in this list are separated into
3 broad categories: (i) Surveillance, Outbreaks & Risks; (ii) Vector
Control and (iii) Virology, Symptoms, Manifestations. Most were
brought to our attention by the Science Alert feature of the journal
Science.

For a searchable, annotated compilation of more than 600 resources
published from 1940* onward, see the Environmental Risk Analysis
Program's WEST NILE VIRUS BIBLIOGRAPHY
<http://environmentalrisk.cornell.edu/WNV/>. (*The 1940 entry by
Smithburn et al. reports the first identification and naming of WNV!)
-- Lois Levitan

----------

SURVEILLANCE, OUTBREAKS & RISKS

Birds, Migration and Emerging Zoonoses: West Nile Virus, Lyme
Disease, Influenza A and Enteropathogens.
      Kurt D Reed, Jennifer K Meece, James S Henkel, and Sanjay K Shukla
      Clin Med Res 1 Jan 2003 1(1): p. 5.
      http://highwire.stanford.edu/cgi/medline/pmid;15931279

An Epidemiological Model for West Nile Virus: Invasion Analysis and
Control Applications.
     Wonham, Marjorie J, de Camino Beck, T, Lewis MA. 2004.
     Proc. R. Soc. Lond B 271, 501-507.
    <http://www.math.ualberta.ca/~mathbio/publications.html>

First report of West Nile Virus in Mosquitoes from Lubbock County, Texas.
     CM Bradford, MA Nascarella, TH Burns, JR Montford, EJ Marsland,
CB Pepper, and SM Presley
      J Am Mosq Control Assoc 1 Mar 2005 21(1): p. 102.
      http://highwire.stanford.edu/cgi/medline/pmid;15825772

Global Health Impacts of Floods: Epidemiologic Evidence
      Mike Ahern, R. Sari Kovats, Paul Wilkinson, Roger Few, and Franziska
      Matthies
      Epidemiol. Rev. 2005; 27(1): p. 36-46
      http://epirev.oxfordjournals.org//cgi/content/extract/27/1/36?ct

Impact of West Nile virus outbreak upon St. Tammany Parish Mosquito
Abatement District.
      CT Palmisano, V Taylor, K Caillouet, B Byrd, and DM Wesson
      J Am Mosq Control Assoc 1 Mar 2005 21(1): p. 33.
      http://highwire.stanford.edu/cgi/medline/pmid;15825759

Metro Atlanta Responds to West Nile Virus: a Coordinated Public Health Response
      J Willis
      Ethn Dis 1 Mar 2005 15(2 Suppl 2): p. S49.
      http://highwire.stanford.edu/cgi/medline/pmid;15822839

Mosquito Surveillance for West Nile Virus in Southeastern Wisconsin -2002.
     Jennifer K Meece, James S Henkel, Linda Glaser, and Kurt D Reed
      Clin Med Res 1 Jan 2003 1(1): p. 37.
      http://highwire.stanford.edu/cgi/medline/pmid;15931283

Persistence of Antibodies to West Nile Virus in Naturally Infected
Rock Pigeons (Columba livia)
      Gibbs,Samantha E J, Douglas M. Hoffman, Lillian M. Stark, Nicole
L. Marlenee, Bradley J. Blitvich,
      Barry J. Beaty, and David E. Stallknecht
      Clin. Diagn. Lab. Immunol. 2005; 12(5): p. 665-667
      http://cdli.asm.org/cgi/content/abstract/12/5/665?ct

Quantification of West Nile Virus in Vector Mosquito Saliva.
      L Colton, BJ Biggerstaff, A Johnson, and RS Nasci
      J Am Mosq Control Assoc 1 Mar 2005 21(1): p. 49.
      http://highwire.stanford.edu/cgi/medline/pmid;15825761

Risks for Ross River Virus Disease in Tropical Australia
      David Harley, Scott Ritchie, Chris Bain, and Adrian C Sleigh
      Int. J. Epidemiol. 2005; 34(3): p. 548-555
      http://ije.oxfordjournals.org/cgi/content/abstract/34/3/548?ct [abstract]
      http://ije.oxfordjournals.org/cgi/reprint/34/3/548 [pdf]

Risks of Blood Transfusion
      LT Goodnough
      Anesthesiol Clin North America 1 Jun 2005 23(2): p. 241.
      http://highwire.stanford.edu/cgi/medline/pmid;15922896

Serological Evidence of West Nile Virus Activity in El Salvador
      LILIAN CRUZ, VICTOR M. CARDENAS, MAURICIO ABARCA, TITO RODRIGUEZ,
      ROBERTO FLORES REYNA, MARIO V. SERPAS, ROBERT E. FONTAINE, DAVID W. C.
      BEASLEY, AMELIA P. A. TRAVASSOS DA ROSA, SCOTT C. WEAVER, ROBERT B.
      TESH, ANN M. POWERS, and GLORIA SUAREZ-RANGEL
      Am J Trop Med Hyg. 2005; 72(5): p. 612-615
      http://www.ajtmh.org/cgi/content/abstract/72/5/612?ct

Serological Evidence of Exposure of Wild Mammals to Flavivirures in
the Central and Eastern United States
      J. JEFFREY ROOT, JEFFREY S. HALL, ROBERT G. MCLEAN, NICOLE L.
      MARLENEE, BARRY J. BEATY, JUSTIN GANSOWSKI, and LARRY CLARK
      Am J Trop Med Hyg. 2005; 72(5): p. 622-630
      http://www.ajtmh.org/cgi/content/abstract/72/5/622?ct

Serologic Survey of Cats and Dogs during an Epidemic of West Nile
Virus Infection in Humans.
      JC Kile, NA Panella, N Komar, CC Chow, A MacNeil, B Robbins, and
ML Bunning
      J Am Vet Med Assoc 15 Apr 2005 226(8): p. 1349.
      http://highwire.stanford.edu/cgi/medline/pmid;15844427

West Nile Virus: the buzz on Ottawa residents' awareness, attitudes
and practices.
      SD Wilson, M Varia, LY Lior, and Field Epidemiology Summer Course
      Can J Public Health 1 Mar 2005 96(2): p. 109.
      http://highwire.stanford.edu/cgi/medline/pmid;15850029

-------
VECTOR CONTROL & REPELLENTS

CDC: New Repellents for West Nile Fight
      Bridget M. Kuehn
      JAMA. June 1 2005. 293 (21):2583.
      http://jama.ama-assn.org/cgi/content/extract/293/21/2583?ct

Development of a HPLC/Tandem-MS Method for the Analysis of the
Larvicides Methoprene, Hydroprene, and Kinoprene at Trace Levels
Using Diels-Alder Derivatization.
      PA Aronov, K Dettmer, JA Christiansen, AJ Cornel, and BD Hammock
      J Agric Food Chem 4 May 2005 53(9): p. 3306.
      http://highwire.stanford.edu/cgi/medline/pmid;15853364

Fight the Bite!: Avoid Mosquito Bites to Prevent West Nile Virus.
      Nursing 1 Jun 2005 35 Travel Nursing 2005: p. 24.
      http://highwire.stanford.edu/cgi/medline/pmid;15933554

---
VIROLOGY, SYMPTOMS, MANIFESTATIONS

A Recombinant Envelope Protein Vaccine against West Nile Virus.
      M Ledizet, K Kar, HG Foellmer, T Wang, SL Bushmich, JF Anderson,
E Fikrig, and RA Koski
      Vaccine 10 Jun 2005 23(30): p. 3915.
      http://highwire.stanford.edu/cgi/medline/pmid;15917113

Antibody Neutralizes West Nile Virus.
      Lab Anim (NY) 1 Jun 2005 34(6): p. 10.
      http://highwire.stanford.edu/cgi/medline/pmid;15924118

Balance and Gait Abnormalities of a Child With West Nile Virus Infection.
     Troy D Moon, Adi Nadimpalli, Emily B Martin, Myriam A Ortiz, and
Russell B Van Dyke
     Pediatr Infect Dis J 1 Jun 2005 24(6): p. 568.
     http://highwire.stanford.edu/cgi/medline/pmid;15933576

Characterization of Neutralizing Antibodies to West Nile Virus.
      MD Sanchez, TC Pierson, D McAllister, SL Hanna, BA Puffer, LE Valentine,
      MM Murtadha, JA Hoxie, and RW Doms
      Virology 25 May 2005 336(1): p. 70.
      http://highwire.stanford.edu/cgi/medline/pmid;15866072

Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic
Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect
Mice against Lethal Challenge with West Nile Virus
      Claire Y.-H. Huang, Shawn J. Silengo, Melissa C. Whiteman, and
Richard M. Kinney
      J. Virol. 2005; 79(12): p. 7300-7310
      http://jvi.asm.org/cgi/content/abstract/79/12/7300?ct

Comparison of Immunohistochemistry and Virus Isolation for Diagnosis
of West Nile Virus
      Angela E. Ellis, Daniel G. Mead, Andrew B. Allison, Samantha E. J. Gibbs,
      Nicole L. Gottdenker, David E. Stallknecht, and Elizabeth W. Howerth
      J. Clin. Microbiol. 2005; 43(6): p. 2904-2908
      http://jcm.asm.org/cgi/content/abstract/43/6/2904?ct

Complement Activation Is Required for Induction of a Protective Antibody
Response against West Nile Virus Infection
      Erin Mehlhop, Kevin Whitby, Theodore Oliphant, Anantha Marri,
Michael Engle, and Michael S. Diamond
      J. Virol. 2005; 79(12): p. 7466-7477
      http://jvi.asm.org/cgi/content/abstract/79/12/7466?ct

Detection of West Nile virus and Japanese encephalitis virus using
      real-time PCR with a probe common to both viruses.
      K Shirato, H Miyoshi, H Kariwa, and I Takashima
      J Virol Methods 1 Jun 2005 126(1-2): p. 119.
      http://highwire.stanford.edu/cgi/medline/pmid;15847927

Development of a humanized monoclonal antibody with therapeutic
      potential against West Nile virus.
      Theodore Oliphant, Michael Engle, Grant E Nybakken, Chris Doane,
      Syd Johnson, Ling Huang, Sergey Gorlatov, Erin Mehlhop, Anantha Marri,
      Kyung Min Chung, Gregory D Ebel, Laura D Kramer, Daved H Fremont,
      and Michael S Diamond
      Nat Med 24 Apr 2005.
      http://highwire.stanford.edu/cgi/medline/pmid;15852016

Differential expression of domain III neutralizing epitopes on the
envelope proteins of West Nile virus strains.
      L Li, AD Barrett, and DW Beasley
      Virology 25 Apr 2005 335(1): p. 99.
      http://highwire.stanford.edu/cgi/medline/pmid;15823609

Domain-based Homology Modeling and Mapping of the Conformational
      Epitopes of Envelope Glycoprotein of West Nile Virus
      J Mol Model (Online) 3 May 2005.
      http://highwire.stanford.edu/cgi/medline/pmid;15868152

Duplex Microsphere-Based Immunoassay for Detection of Anti-West Nile
Virus and Anti-St. Louis Encephalitis Virus Immunoglobulin M
Antibodies
      Johnson, Alison J, Amanda J. Noga, Olga Kosoy, Robert S. Lanciotti,
      Alicia A. Johnson, and Brad J. Biggerstaff
      Clin. Diagn. Lab. Immunol. 2005; 12(5): p. 566-574
      http://cdli.asm.org/cgi/content/abstract/12/5/566?ct

Envelope Protein Glycosylation Status Influences Mouse Neuroinvasion
Phenotype of Genetic Lineage 1 West Nile Virus Strains
      David W. C. Beasley, Melissa C. Whiteman, Shuliu Zhang, Claire Y.-H.
      Huang, Bradley S. Schneider, Darci R. Smith, Gregory D. Gromowski,
      Stephen Higgs, Richard M. Kinney, and Alan D. T. Barrett
      J. Virol. 2005; 79(13): p. 8339-8347
      http://jvi.asm.org/cgi/content/abstract/79/13/8339?ct

Flavivirus Activates Phosphatidylinositol 3-Kinase Signaling To Block
Caspase-Dependent Apoptotic Cell Death at the Early Stage of Virus
Infection
      Chyan-Jang Lee, Ching-Len Liao, and Yi-Ling Lin
      J. Virol. 2005; 79(13): p. 8388-8399
      http://jvi.asm.org/cgi/content/abstract/79/13/8388?ct

Focal Neurological Deficits and West Nile Virus Infection
      NK Watson, RE Bartt, SA Houff, SE Leurgans, and MJ Schneck
      Clin Infect Dis 1 Apr 2005 40(7): p. e59.
      http://highwire.stanford.edu/cgi/medline/pmid;15824976

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of
Flaviviruses
      Jorge L. Munoz-Jordan, Maudry Laurent-Rolle, Joseph Ashour, Luis
      Martinez-Sobrido, Mundrigi Ashok, W. Ian Lipkin, and Adolfo
      Garcia-Sastre
      J. Virol. 2005; 79(13): p. 8004-8013
      http://jvi.asm.org/cgi/content/abstract/79/13/8004?ct

Initial DWI and ADC Imaging May Predict Outcome in Acute Disseminated
Encephalomyelitis: Report of Two Cases of Brain Stem Encephalitis
      H Axer, A Ragoschke-Schumm, J Bottcher, C Fitzek, O W Witte, and S
      Isenmann
      J. Neurol. Neurosurg. Psychiatry. 2005; 76(7): p. 996-998
      http://www.jnnp.com/cgi/content/abstract/76/7/996?ct

Misinterpretation of Liver-Function Tests and West Nile Virus
Infection in Children
      Hochman, Jay A
      Pediatrics. 2005; 115(5): p. 1445
      http://pediatrics.aappublications.org/cgi/content/extract/115/5/1445?ct

Misinterpretation of Liver-Function Tests and West Nile Virus
Infection in Children: In Reply
      Yim, Robert and Ellen R. Wald
      Pediatrics. 2005; 115(5): p. 1445-a--a1446
      http://pediatrics.aappublications.org/cgi/content/extract/115/5/1445-a?ct

Molecular typing of west nile virus, dengue, and st. Louis
      encephalitis using multiplex sequencing.
      T Vinayagamoorthy, K Mulatz, M Drebot, and R Hodkinson
      J Mol Diagn 1 May 2005 7(2): p. 152.
      http://highwire.stanford.edu/cgi/medline/pmid;15858138

[Morphological and immunohistochemical changes in tissues of the lung,
      myocardium and kidney in experimental West Nile fever]
      Vopr Virusol 1 Mar 2005 50(2): p. 37.
      http://highwire.stanford.edu/cgi/medline/pmid;15881396

One-year Sequelae in Patients with West Nile Virus Encephalitis and
Meningitis in Louisiana.
      Ou, A C and RC Ratard
      J La State Med Soc 1 Jan 2005 157(1): p. 42.
      http://highwire.stanford.edu/cgi/medline/pmid;15887668

Peptide Inhibitors of Dengue Virus and West Nile Virus Infectivity.
     Yancey M Hrobowski, Robert F Garry, and Scott F Michael
      Virol J 1 Jun 2005 2(1): p. 49.
      http://highwire.stanford.edu/cgi/medline/pmid;15927084

Persistence of Antibodies to West Nile Virus in Naturally Infected
Rock Pigeons (Columba livia).
      Gibbs, S E, DM Hoffman, LM Stark, NL Marlenee, BJ Blitvich, BJ
Beaty, and DE Stallknecht
      Clin Diagn Lab Immunol 1 May 2005 12(5): p. 665.
      http://highwire.stanford.edu/cgi/medline/pmid;15879030

The Rash of West Nile Virus Infection
      Ronald Gorsche and Peter Tilley
      Can. Med. Assoc. J. 2005; 172(11): p. 1440
      http://www.cmaj.ca/cgi/content/full/172/11/1440?ct

Recombinant Canarypox Vectored West Nile Vrus (WNV) Vaccine Protects
Dogs and Cats against a Mosquito WNV challenge.
      K Karaca, R Bowen, LE Austgen, M Teehee, L Siger, D Grosenbaugh,
      L Loosemore, JC Audonnet, R Nordgren, and JM Minke
      Vaccine 31 May 2005 23(29): p. 3808.
      http://highwire.stanford.edu/cgi/medline/pmid;15893618

The Suitability of Yellow Fever and Japanese Encephalitis Vaccines for
      Immunization against West Nile Virus.
      Galina Yamshchikov, Victoria Borisevich, Chun Wai Kwok, Ryan
Nistler, Jake Kohlmeier,
      Alexey Seregin, Elena Chaporgina, Stephen Benedict, and Vladimir
Yamshchikov
      Vaccine 3 Jun 2005.
      http://highwire.stanford.edu/cgi/medline/pmid;15939510

Viral Encephalitis in Humans
      John Greenlee
      Neurology. 2005; 64(9): p. 1668-a
      http://www.neurology.org/cgi/content/full/64/9/1668-a?ct

West Nile Virus Infection and its Neurological Manifestations.
      Ken Madden
      Clin Med Res 1 Apr 2003 1(2): p. 145.
      http://highwire.stanford.edu/cgi/medline/pmid;15931302

West Nile Virus Encephalitis.
      Nick I Batalis, Luis Galup, Sherif R Zaki, and Joseph A Prahlow
      Am J Forensic Med Pathol 1 Jun 2005 26(2): p. 192.
      http://highwire.stanford.edu/cgi/medline/pmid;15894859

West Nile Virus Encephalitis Infection in a Heart Transplant
Recipient: a Case Report.
      D Bragin-Sanchez and PP Chang
      J Heart Lung Transplant 1 May 2005 24(5): p. 621.
      http://highwire.stanford.edu/cgi/medline/pmid;15896763

West Nile virus meningitis in a chronic immunosuppressed patient with
Rheumatoid Arthritis.
      Batsis, John A and Michael P Phy
      Clin Rheumatol 23 Apr 2005.
      http://highwire.stanford.edu/cgi/medline/pmid;15856365

Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?
[Infrastructure]
      Paul A. Offit
      Health Affairs. 24 (3): 622-630
     http://content.healthaffairs.org/cgi/content/abstract/24/3/622?ct
During the past fifty years, the number of pharmaceutical companies
making vaccines has decreased dramatically, and those that still make
vaccines have reduced resources to make new ones. Pharmaceutical
companies are gradually abandoning vaccines because the research,
development, testing, and manufacture of vaccines are expensive and
because the market to sell vaccines is much smaller than the market
for other drug products. Congressional action could assure both a
steady supply of existing vaccines and the promise of vaccines for
the future.

Why Certain Vaccines Have Been Delayed Or Not Developed At All
[Perspective, Infrastructure]
      Stanley A. Plotkin
      Health Affairs, Vol 24, Issue 3, 631-634
Vaccine development is a long process, with the time from early
research to licensure steadily increasing. At one time the process
took about ten years; now it takes closer to fifteen to twenty years.
The process begins with investigators in universities or biotech
firms who have an idea. However, to take things further, there must
be a vaccine manufacturer, a regulatory authority ready to give
permission for the use of the vaccine, and public health authorities
that will recommend and foster vaccination.

--------------------------

Lois Levitan, PhD Program Leader
Environmental Risk Analysis Program (ERAP)
Department of Communication
311 Kennedy Hall, Cornell University
Ithaca, New York USA 14853-5601

Phone: (607) 255-4765 Fax: (607) 254-1322
Email: LCL3@cornell.edu
Web: http://environmentalrisk.cornell.edu
--
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
WESTNILEVIRUS-L is an email discussion group for communication
and discussion about West Nile Virus, particularly regarding policy,
risk reduction and public education issues. It is hosted at Cornell
University and moderated by Dr. Lois Levitan, Program Leader of
Cornell's Environmental Risk Analysis Program (ERAP).

Subscribers are encouraged to post to the group by sending
messages to <envrisk@cornell.edu>. Put "WNV Listserv" in
the subject line and send unformatted text, without attachments.

To subscribe (or unsubscribe), send an email request with
  your name and contact information to <envrisk@cornell.edu>.
To receive messages once a day in digest format, subscribers should
send an email to <listproc@cornell.edu> with message:
"set WESTNILEVIRUS-L mail digest-nomime".

Postings are archived at
<http://environmentalrisk.cornell.edu/WNV/WNV-LArchive>.

SEE ERAP's WEST NILE VIRUS BIBLIOGRAPHIES & OTHER RESOURCES,
on the web at: <http://environmentalrisk.cornell.edu/WNV/>
Received on Fri, 17 Jun 2005 11:29:52 -0400

This archive was generated by hypermail 2.1.8 : June 29 2005 EDT